Holger Albrecht

Measurement of ataxic symptoms with a graphic tablet: standard values in controls and validity in Multiple Sclerosis patients

Lutz-Peter Erasmus, Stefania Sarno, Holger Albrecht et al. · Journal of Neuroscience Methods · 2001 · 78 citations

Neuropsychology, Graphic Tablet, Multiple Sclerosis Patients +13

Acquired pendular nystagmus in multiple sclerosis: an examiner-blind cross-over treatment study of memantine and gabapentin

M. Starck, Holger Albrecht, W. Pöllmann et al. · Journal of Neurology · 2009 · 78 citations

Neurobiology Of Disease, Neurological Disorder, Clinical Neurology +8

Real-world persistence and benefit–risk profile of fingolimod over 36 months in Germany

Tjalf Ziemssen, Michael Lang, Björn Tackenberg et al. · Neurology Neuroimmunology & Neuroinflammation · 2019 · 34 citations · Full text

Long-term real-world effectiveness and safety of fingolimod over 5 years in Germany

Tjalf Ziemssen, Michael Lang, Stephan Schmidt et al. · Journal of Neurology · 2022 · 21 citations · Full text

Natalizumab treatment shows low cumulative probabilities of confirmed disability worsening to EDSS milestones in the long-term setting

María Trojano, Helmut Butzkueven, Ludwig Kappos et al. · Multiple Sclerosis and Related Disorders · 2018 · 18 citations · Full text